Inappropriate sinus tachycardia: Difference between revisions

Jump to navigation Jump to search
Michael Maddaleni (talk | contribs)
Michael Maddaleni (talk | contribs)
Line 11: Line 11:


==Pathophysiology==
==Pathophysiology==
The mechanism of the arrhythmia primarily involves the [[sinus node]] and peri-nodal tissue<ref>{{cite journal |doi=10.1054/jelc.2000.9648 |title=Electrophysiologic findings of a patient with inappropriate sinus tachycardia cured by selective radiofrequency catheter ablation |year=2000 |last1=Sato |first1=Toshiaki |last2=Mitamura |first2=Hideo |last3=Murata |first3=Mitsushige |last4=Shinagawa |first4=Kaori |last5=Miyoshi |first5=Shunichiro |last6=Kanki |first6=Hideaki |last7=Takatsuki |first7=Seiji |last8=Soejima |first8=Kyoko |last9=Miyazaki |first9=Toshihisa |journal=Journal of Electrocardiology |volume=33 |issue=4 |pages=381–6 |pmid=11099363}}</ref> and does not require the [[Atrioventricular node|AV node]] for maintenance.  These patients have no apparent heart disease or other causes of sinus tachycardia. IST is thought to be due to abnormal autonomic control or [[dysautonomia]].  An autoimmune mechanism has been suggested as several studies have detected autoantibodies that activate beta adrenoreceptors in a portion of patients.<ref>{{cite journal |doi=10.1016/j.hrthm.2006.06.011 |title=Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β andrenergic receptors |year=2006 |last1=Chiale |first1=Pablo A. |last2=Garro |first2=Hugo A. |last3=Schmidberg |first3=Jorge |last4=Sánchez |first4=Rubén A. |last5=Acunzo |first5=Rafael S. |last6=Lago |first6=Manuel |last7=Levy |first7=Gabriela |last8=Levin |first8=Mariano |journal=Heart Rhythm |volume=3 |issue=10 |pages=1182–6 |pmid=17018348}}</ref><ref>{{cite journal |doi=10.1016/j.hrthm.2006.07.019 |title=Inappropriate sinus tachycardia and beta-receptor autoantibodies: A mechanistic breakthrough? |year=2006 |last1=Nattel |first1=Stanley |journal=Heart Rhythm |volume=3 |issue=10 |pages=1187–8 |pmid=17018349}}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Revision as of 12:24, 10 September 2012

Inappropriate sinus tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Inappropriate Sinus Tachycardia from other Medical Conditions

Epidemiology and Demographics

Diagnosis

Diagnostic Criteria

History and Symptoms

Electrocardiogram

Treatment

ACC/AHA/ESC Treatment Guidelines

Medical Therapy

Surgery

Case Studies

Case #1

Inappropriate sinus tachycardia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Inappropriate sinus tachycardia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Inappropriate sinus tachycardia

CDC on Inappropriate sinus tachycardia

Inappropriate sinus tachycardia in the news

Blogs on Inappropriate sinus tachycardia

Directions to Hospitals Treating Inappropriate sinus tachycardia

Risk calculators and risk factors for Inappropriate sinus tachycardia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: IST; chronic nonparoxysmal sinus tachycardia

Overview

Historical Perspective

Pathophysiology

Epidemiology and Demographics

The disorder is uncommon.

Sex

More common in women.

Age

Most patients are in their late 20s to early 30s.

Differentiating Inappropriate Sinus Tachycardia from other Medical Conditions

The following medical conditions must be excluded as a cause of tachycardia:

Differentiating Inappropriate Sinus Tachycardia from other Supraventricular Arrhythmias

Diagnosis

Diagnostic Criteria

No formal diagnostic criteria exist. A diagnosis of Inappropriate sinus tachycardia is primarily a diagnosis of exclusion and the following must be observed:

Symptoms

Symptoms reported by patients vary in frequency and severity. Symptoms associated with Inappropriate sinus tachycardia include:

Treatment

Treatments in the form of pharmacological therapy or catheter ablation are available, although it is currently difficult to treat successfully.

Beta-blockers

In so far as the pathophysiology of IST involves abnormal sensitivity to adrenaline, betaa-blockers can be helpful.

Calcium Channel Blockers

Although calcium channel blockers slow conduction through the AV node, they have been marginally effective in the treatment of IST.

Ivabradine

A new selective sinus node inhibitor Ivabradine is also being used to treat IST.

Treatments Related to Dysautonomia and POTS

In so far as the underlying pathophysiology may involve a dysautonomia and features of Postural orthostatic tachycardia syndrome (POTS), some therapies more commonly used to treat these disorders have been tried:

Fludrocortisone (Florinef)

POTS and dysautonomia have been associated with decreases in blood volume, and this drug promotes sodium retention.

Midodrine

Midodrine increases vasoconstriction, and prevents falls in blood pressure.

Serotonin-reuptake inhibitors (SSRIs)

SSRIs have proven effective in treating some patients with dysautonomia.

Catheter Ablation

Invasive treatments include forms of Catheter ablation has gained favor among electrophysiologists in the treatment of IST.

Sinus Node Modification

This procedure involves selective ablation of the sinus node. The rhythm reoccurs in 80% of cases.

Complete Sinus Node Ablation

This procedure requires implantation of a Permanent Artificial pacemaker)

AV Node Ablation

In cases resistant to sinus node ablation, AV node ablation with creation of an iatrogenic complete heart block, may be neccessary. This procedure requires implantation of a permanent artificial pacemaker.

See also

References



Template:WikiDoc Sources